• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.72 Down 0.03(3.79%) Dec 19, 4:04PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development5,340  7,711  4,989  
    Selling General and Administrative4,121  4,115  3,637  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (9,460) (11,827) (8,626)
    Income from Continuing Operations
    Total Other Income/Expenses Net660  (2,271)2,906  
    Earnings Before Interest And Taxes(8,801)(14,098)(5,720)
    Interest Expense -  397   -  
    Income Before Tax(8,801)(14,495)(5,720)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(8,801)(14,495)(5,720)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (8,801) (14,495) (5,720)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (8,801) (14,495) (5,720)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.